⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MNOV News
Medicinova, Inc.
MediciNova CEO Provides Shareholder Update
globenewswire.com
MNOV
MediciNova to Participate in the Maxim Growth Summit
globenewswire.com
MNOV
Form 8-K
sec.gov
MNOV
MediciNova Announces Topline Results from MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)
globenewswire.com
MNOV
MediciNova Announces Completion of Last Patient, Last Visit in the Double-Blind Portion of the Phase 2b/3 COMBAT-ALS Trial of MN-166 (Ibudilast)
globenewswire.com
MNOV
ROTH to Host 5th Annual Healthcare Opportunities Conference on September 29 in New York City
globenewswire.com
ANVS
CRVO
MGNX
MNOV
MediciNova to Participate in Two Investor Conferences in September
globenewswire.com
MNOV
Form 8-K
sec.gov
MNOV
Form 8-K
sec.gov
MNOV
MediciNova Announces Patient Enrollment Milestone Achieved in SEANOBI Study Expanded-Access-Program Evaluating MN‑166 (ibudilast) in ALS patients
globenewswire.com
MNOV